New Medicaid Bulletin Articles Available as of May 2

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:

• Patient Driven Payment Model and the Implementation of the Optional State Assessment
• Lenacapavir Injection, for Subcutaneous Use (Sunlenca®) HCPCS Code J3490 - Unclassified Drugs: Billing Guidelines
• Ublituximab-Xiiy Injection, for Intravenous Use (Briumvi™) HCPCS Code J3590 - Unclassified Biologics: Billing Guidelines
• Pegfilgrastim-FpgkInjection, for Subcutaneous Use (Stimufend®) HCPCS Code J3590 - Billing Guidelines
• Fecal Microbiota, Live - Jslm Suspension, for Rectal Use (Rebyota™) HCPCS Code J3590 - Unclassified biologics: Billing Guidelines
• Bendamustine Hydrochloride Injection, for Intravenous Use (Baxter) HCPCS Code J9999 - Not Otherwise Classified, Antineoplastic: Billing Guidelines

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.